Safety and efficacy of current DAA regimens in kidney and liver transplant recipients with hepatitis C: results from the HCV-TARGET study | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Safety and efficacy of current DAA regimens in kidney and liver transplant recipients with hepatitis C: results from the HCV-TARGET study

Saxena V, Khungar V, Verna EC, et al. Safety and efficacy of current DAA regimens in kidney and liver transplant recipients with hepatitis C: results from the HCV-TARGET study. Hepatology. 2017;66(4):1090-1101.

Publication Type:

Journal Article

Authors:

Saxena, Varun; Khungar, Vandana; Verna, Elizabeth C.; et, al

Source:

Hepatology, Volume 66, Issue 4, p.1090-1101 (2017)

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/28504842

Export Citation:

RIS Format

Top